<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Zijlstra, A.J.E.</title>
    <link>http://repub.eur.nl/res/aut/9638/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Tumor suppressor function of Bruton tyrosine kinase is independent of its catalytic activity (Article)</title>
      <link>http://repub.eur.nl/res/pub/8158/</link>
      <pubDate>2005-01-01T00:00:00Z</pubDate>
      <description>During B-cell development in the mouse, Bruton tyrosine kinase (Btk) and
      the adaptor protein SLP-65 (Src homology 2 [SH2] domain-containing
      leukocyte protein of 65 kDa) limit the expansion and promote the
      differentiation of pre-B cells. Btk is thought to mainly function by
      phosphorylating phospholipase Cgamma2, which is brought into close
      proximity of Btk by SLP-65. However, this model was recently challenged by
      the identification of a role for Btk as a tumor suppressor in the absence
      of SLP-65 and by the finding that Btk function is partially independent of
      its kinase activity. To investigate if enzymatic activity is critical for
      the tumor suppressor function of Btk, we crossed transgenic mice
      expressing the kinase-inactive K430R-Btk mutant onto a Btk/SLP-65
      double-deficient background. We found that K430R-Btk expression rescued
      the severe developmental arrest at the pre-B-cell stage in Btk/SLP-65
      double-deficient mice. Moreover, K430R-Btk could functionally replace
      wild-type Btk as a tumor suppressor in SLP-65- mice: at 6 months of age,
      the observed pre-B-cell lymphoma frequencies were approximately 15% for
      SLP-65- mice, 44% for Btk/SLP-65-deficient mice, and 14% for K430R-Btk
      transgenic mice on the Btk/SLP-65-deficient background. Therefore, we
      conclude that Btk exerts its tumor suppressor function in pre-B cells as
      an adaptor protein, independent of its catalytic activity</description>
    </item>
  </channel>
</rss>